About Tangible Pharmaceuticals
Tangible Pharmaceuticals offers products and services including Branded Formulations and Research and Development Services.
- SectorsHealthcare
- Email••••••••
- Legal Name Tangible Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 26 Mar, 2019
- Jurisdiction Mirzapur, Uttar Pradesh, India
- Annual Revenue₹27.9 Lakh
FY 2025 · -30% YoY
- Net Loss-₹1.4 Lakh
FY 2025 · -5% margin
- EBITDA-₹1.4 Lakh
FY 2025 · -5% margin
Associated legal entities of Tangible Pharmaceuticals
Tangible Pharmaceuticals operates through Tangible Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tangible Pharmaceuticals Private Limited CIN U24239UP2019PTC115051 | Active | 26 Mar 2019 | Mirzapur, Uttar Pradesh | ₹0.3 Cr | – | 2 | View details |
Products & Services of Tangible Pharmaceuticals
Tangible Pharmaceuticals offers a comprehensive portfolio of products and services, including Branded Formulations and Research and Development Services.
Quality, affordable, and branded formulations are provided for various uses in the pharmaceutical sector.
New formulas are developed through regular R&D activities to support pharmaceutical advancements.
Board of directors of Tangible Pharmaceuticals Private Limited (Tangible Pharmaceuticals)
Tangible Pharmaceuticals Private Limited is the primary company behind Tangible Pharmaceuticals. The board of Tangible Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Prabha Pandey, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prabha Pandey DIN 08400084 | Director | 26 Mar 2019 | 7 yrs 6 mo | Tangible Pharmaceuticals Private Limited |
| Raghvendra Narayan Singh DIN 08400085 | Director | 26 Mar 2019 | 7 yrs 6 mo | Tangible Pharmaceuticals Private Limited |
Financials of Tangible Pharmaceuticals
Figures of Tangible Pharmaceuticals Private Limited, the primary company behind Tangible Pharmaceuticals, for FY 2025. Revenue was ₹27.9 Lakh (-30% year on year). Net loss was -₹1.4 Lakh (-5% margin). EBITDA was -₹1.4 Lakh (-5% margin). Revenue has grown at a compounded annual rate of -7% over three years and -4% over five years.
- ₹27.9 LakhRevenue · FY 2025 · -30% YoY
- -₹1.4 LakhNet loss · -5% margin
- -₹1.4 LakhEBITDA · -5% margin
- ₹1 LakhPaid-up capital
- -7%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Tangible Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Tangible Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Tangible Pharmaceuticals
10 companies that operate in the same segment as Tangible Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tangible Pharmaceuticals
The primary company behind Tangible Pharmaceuticals, Tangible Pharmaceuticals Private Limited, reported revenue of ₹27.9 Lakh for FY 2025, down 30% year on year.
Tangible Pharmaceuticals is recognized as a renowned player in the pharmaceutical industry, where a wide range of quality, affordable, and branded formulations is offered. Consistent growth has been achieved by the company, surpassing the Indian markets performance, while efforts are made to build brand power and reach the status of top pharma entities. Innovation is facilitated through regular RD activities, and a vision is held to be acknowledged as a leading company. The mission emphasizes the provision of advanced medicine and trusted care, with operations based in Mumbai, India.
Tangible Pharmaceuticals offers Branded Formulations and Research and Development Services.
Tangible Pharmaceuticals operates through Tangible Pharmaceuticals Private Limited.
The legal entities of Tangible Pharmaceuticals currently have 2 directors, including Prabha Pandey, Raghvendra Narayan Singh.